{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:50:25Z","timestamp":1792785025255,"version":"4.5.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Baoding Self-raised Fund Project","award":["17ZF176"],"award-info":[{"award-number":["17ZF176"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-22773-x","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T13:29:22Z","timestamp":1762349362000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The impact of continuous intravenous administration of heparin on coagulation dysfunction and organ failure in patients with sepsis"],"prefix":"10.1038","volume":"15","author":[{"given":"Qinlong","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxu","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tenghao","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanbiao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,5]]},"reference":[{"issue":"1","key":"22773_CR1","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s13054-020-02950-2","volume":"24","author":"M Bauer","year":"2020","unstructured":"Bauer, M. et al. Mortality in sepsis and septic shock in Europe, North America and Australia between 2009 and 2019- results from a systematic review and meta-analysis. Crit. Care. 24(1), 239 (2020).","journal-title":"Crit. Care."},{"issue":"8","key":"22773_CR2","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1080\/17474086.2018.1500173","volume":"11","author":"M Levi","year":"2018","unstructured":"Levi, M. & Sivapalaratnam, S. Disseminated intravascular coagulation: an update on pathogenesis and diagnosis. Expert Rev. Hematol. 11(8), 663\u2013672 (2018).","journal-title":"Expert Rev. Hematol."},{"key":"22773_CR3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12959-020-00231-0","volume":"18","author":"JC Chang","year":"2020","unstructured":"Chang, J. C. Disseminated intravascular coagulation: new identity as endotheliopathy-associated vascular microthrombotic disease based on in vivo hemostasis and endothelial molecular pathogenesis. Thromb. J. 18, 25 (2020).","journal-title":"Thromb. J."},{"issue":"8","key":"22773_CR4","doi-asserted-by":"publisher","first-page":"e677","DOI":"10.1097\/CCM.0000000000003839","volume":"47","author":"Z Cheng","year":"2019","unstructured":"Cheng, Z. et al. Circulating Histones Are Major Mediators of Multiple Organ Dysfunction Syndrome in Acute Critical Illnesses. Crit. Care Med. 47(8), e677\u2013e684 (2019).","journal-title":"Crit. Care Med."},{"issue":"1","key":"22773_CR5","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s40635-015-0072-z","volume":"3","author":"T Iba","year":"2015","unstructured":"Iba, T. et al. Heparins attenuated histone-mediated cytotoxicity in vitro and improved the survival in a rat model of histone-induced organ dysfunction. Intensive Care Med. Exp. 3(1), 36 (2015).","journal-title":"Intensive Care Med. Exp."},{"issue":"3","key":"22773_CR6","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1097\/CCM.0000000000000763","volume":"43","author":"R Zarychanski","year":"2015","unstructured":"Zarychanski, R. et al. The efficacy and safety of heparin in patients with sepsis: a systematic review and metaanalysis. Crit. Care Med. 43(3), 511\u2013518 (2015).","journal-title":"Crit. Care Med."},{"issue":"1","key":"22773_CR7","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12871-021-01545-w","volume":"22","author":"S Fu","year":"2022","unstructured":"Fu, S., Yu, S., Wang, L., Ma, X. & Li, X. Unfractionated heparin improves the clinical efficacy in adult sepsis patients: a systematic review and meta-analysis. BMC Anesthesiol. 22(1), 28 (2022).","journal-title":"BMC Anesthesiol."},{"issue":"11","key":"22773_CR8","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","volume":"47","author":"L Evans","year":"2021","unstructured":"Evans, L. et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 47(11), 1181\u20131247 (2021).","journal-title":"Intensive Care Med."},{"key":"22773_CR9","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1097\/CCM.0b013e31819c06bc","volume":"37","author":"F Jaimes","year":"2009","unstructured":"Jaimes, F. et al. Unfractioned heparin for treatment of sepsis: A randomized clinical trial (The HETRASE Study). Crit. Care Med. 37, 1185\u20131196 (2009).","journal-title":"Crit. Care Med."},{"key":"22773_CR10","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1056\/NEJM197208172870703","volume":"287","author":"D Basu","year":"1972","unstructured":"Basu, D., Gallus, A., Hirsh, J. & Cade, J. A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time. N. Engl. J. Med. 287, 324\u2013327 (1972).","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"22773_CR11","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1055\/s-0037-1616068","volume":"86","author":"FB Taylor Jr","year":"2001","unstructured":"Taylor, F. B. Jr. et al. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb. Haemost. 86(5), 1327\u20131330 (2001).","journal-title":"Thromb. Haemost."},{"issue":"5","key":"22773_CR12","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1093\/ajhp\/zxab380","volume":"79","author":"J Jacobi","year":"2022","unstructured":"Jacobi, J. The pathophysiology of sepsis-2021 update: Part 1, immunology and coagulopathy leading to endothelial injury. Am. J. Health Syst Pharm. 79(5), 329\u2013337 (2022).","journal-title":"Am. J. Health Syst Pharm."},{"issue":"17","key":"22773_CR13","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.3390\/cells12172120","volume":"12","author":"A Unar","year":"2023","unstructured":"Unar, A., Bertolino, L., Patauner, F., Gallo, R. & Durante-Mangoni, E. Pathophysiology of Disseminated Intravascular Coagulation in Sepsis: A Clinically Focused Overview. Cells 12(17), 2120 (2023).","journal-title":"Cells"},{"issue":"1","key":"22773_CR14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1055\/s-0034-1398376","volume":"41","author":"M Levi","year":"2015","unstructured":"Levi, M. & Tv, P. Coagulation in patients with severe sepsis. Semin. Thromb. Hemost. 41(1), 9\u201315 (2015).","journal-title":"Semin. Thromb. Hemost."},{"issue":"5","key":"22773_CR15","first-page":"e0013","volume":"1","author":"S Katayama","year":"2019","unstructured":"Katayama, S. et al. Thrombomodulin, Plasminogen Activator Inhibitor-1 and Protein C Levels, and Organ Dysfunction in Sepsis. Crit. Care Explor. 1(5), e0013 (2019).","journal-title":"Crit. Care Explor."},{"issue":"2","key":"22773_CR16","first-page":"143","volume":"60","author":"J Guo","year":"2021","unstructured":"Guo, J. & Xu, Q. H. The correlation of plasma thrombomodulin plasminogen activator inhibitor-1 and endothelial cell injury in septic patients. Zhonghua Nei Ke Za Zhi 60(2), 143\u2013146 (2021).","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"22773_CR17","doi-asserted-by":"publisher","first-page":"1127099","DOI":"10.3389\/fvets.2023.1127099","volume":"10","author":"S Gaudette","year":"2023","unstructured":"Gaudette, S. et al. Biomarkers of endothelial activation and inflammation in dogs with organ dysfunction secondary to sepsis. Front. Vet Sci. 10, 1127099 (2023).","journal-title":"Front. Vet Sci."},{"issue":"5","key":"22773_CR18","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1097\/ALN.0000000000003122","volume":"132","author":"T Iba","year":"2020","unstructured":"Iba, T. & Levy, J. H. Sepsis-induced Coagulopathy and Disseminated Intravascular Coagulation. Anesthesiology 132(5), 1238\u20131245 (2020).","journal-title":"Anesthesiology"},{"issue":"1","key":"22773_CR19","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40560-023-00672-5","volume":"11","author":"T Iba","year":"2023","unstructured":"Iba, T., Helms, J., Connors, J. M. & Levy, J. H. The pathophysiology, diagnosis, and management of sepsis-associated disseminated intravascular coagulation. J. Intensive Care. 11(1), 24 (2023).","journal-title":"J. Intensive Care."},{"issue":"9","key":"22773_CR20","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.3390\/cells12091222","volume":"12","author":"J Iannucci","year":"2023","unstructured":"Iannucci, J. & Grammas, P. Thrombin, a Key Driver of Pathological Inflammation in the Brain. Cells 12(9), 1222 (2023).","journal-title":"Cells"},{"issue":"10","key":"22773_CR21","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.3390\/ph17101362","volume":"17","author":"R Sultana","year":"2024","unstructured":"Sultana, R. & Kamihira, M. Multifaceted Heparin: Diverse Applications beyond Anticoagulant Therapy. Pharmaceuticals (Basel) 17(10), 1362 (2024).","journal-title":"Pharmaceuticals (Basel)"},{"issue":"8","key":"22773_CR22","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1055\/s-0044-1786990","volume":"50","author":"DJ Arachchillage","year":"2024","unstructured":"Arachchillage, D. J. & Kitchen, S. Pleiotropic Effects of Heparin and its Monitoring in the Clinical Practice. Semin. Thromb. Hemost. 50(8), 1153\u20131162 (2024).","journal-title":"Semin. Thromb. Hemost."},{"issue":"2","key":"22773_CR23","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3390\/ph16020271","volume":"16","author":"J Hogwood","year":"2023","unstructured":"Hogwood, J., Gray, E. & Mulloy, B. Heparin, Heparan Sulphate and Sepsis: Potential New Options for Treatment. Pharmaceuticals (Basel) 16(2), 271 (2023).","journal-title":"Pharmaceuticals (Basel)"},{"issue":"16","key":"22773_CR24","first-page":"4199","volume":"28","author":"AB Kassem","year":"2024","unstructured":"Kassem, A. B. et al. Assessment of the effect of unfractionated heparin administered either by intravenous infusion vs subcutaneous injection on heparin-binding protein, and plasminogen activator inhibitor-1 in critically ill septic patients: a randomized controlled trial. Eur. Rev. Med. Pharmacol. Sci. 28(16), 4199\u20134213 (2024).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"22773_CR25","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12959-024-00653-0","volume":"22","author":"T Totoki","year":"2024","unstructured":"Totoki, T. et al. Heparin therapy in sepsis and sepsis-associated disseminated intravascular coagulation: a systematic review and meta-analysis. Thromb. J. 22, 84 (2024).","journal-title":"Thromb. J."}],"updated-by":[{"DOI":"10.1038\/s41598-026-59004-w","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22773-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22773-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22773-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T12:25:33Z","timestamp":1782303933000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22773-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,5]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["22773"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-22773-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,5]]},"assertion":[{"value":"12 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-026-59004-w","URL":"https:\/\/doi.org\/10.1038\/s41598-026-59004-w","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All clinical investigations had been conducted according to the principles expressed in the Declaration of Helsinki. This study has been approved by the Institutional Review Board of the Affiliated Hospital of Hebei University, and informed consent to participate in this study has been obtained from the participants. The ethical approval number is HDFYLL-KY-2024-001.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate declarations"}}],"article-number":"38781"}}